These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 36483446)

  • 1. Erratum: Influence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccinations on cluster events among patients and staff in a tertiary-care hospital in Germany - CORRIGENDUM.
    Eisenmann M; Rauschenberger V; Knies K; Schwarzmann G; Vogel U; Krone M
    Antimicrob Steward Healthc Epidemiol; 2022; 2(1):e138. PubMed ID: 36483446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) vaccinations on cluster events among patients and staff in a tertiary-care hospital in Germany.
    Eisenmann M; Rauschenberger V; Knies K; Schwarzmann G; Vogel U; Krone M
    Antimicrob Steward Healthc Epidemiol; 2022; 2(1):e26. PubMed ID: 36310790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection Control Measures and Prevalence of SARS-CoV-2 IgG among 4,554 University Hospital Employees, Munich, Germany.
    Erber J; Kappler V; Haller B; Mijočević H; Galhoz A; Prazeres da Costa C; Gebhardt F; Graf N; Hoffmann D; Thaler M; Lorenz E; Roggendorf H; Kohlmayer F; Henkel A; Menden MP; Ruland J; Spinner CD; Protzer U; Knolle P; Lingor P;
    Emerg Infect Dis; 2022 Mar; 28(3):572-581. PubMed ID: 35195515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal Testing for Respiratory and Gastrointestinal Shedding of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Day Care Centers in Hesse, Germany.
    Hoehl S; Kreutzer E; Schenk B; Westhaus S; Foppa I; Herrmann E; Ettrich I; Leondaraki M; Schaible A; Rudych O; Rabenau H; Berger A; Ciesek S
    Clin Infect Dis; 2021 Nov; 73(9):e3036-e3041. PubMed ID: 33388748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum: Feasibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen self-testing in school and summer camp attendees.
    Colom-Cadena A; Martínez-Riveros H; Bordas A; Alonso-García L; Montoro-Fernández M; Romano-deGea P; Vidal-Alaball J; Solà-Segura E; Llibre JM; Revollo B; Casabona J; Agustí C
    Front Pediatr; 2023; 11():1353806. PubMed ID: 38250593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A SARS-CoV-2 Cluster in an Acute Care Hospital.
    Klompas M; Baker MA; Rhee C; Tucker R; Fiumara K; Griesbach D; Bennett-Rizzo C; Salmasian H; Wang R; Wheeler N; Gallagher GR; Lang AS; Fink T; Baez S; Smole S; Madoff L; Goralnick E; Resnick A; Pearson M; Britton K; Sinclair J; Morris CA
    Ann Intern Med; 2021 Jun; 174(6):794-802. PubMed ID: 33556277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrigendum to "The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A review" [J. Pharma. Anal. 11 (2021) 265-271].
    Dwi Rizkita L; Astuti I
    J Pharm Anal; 2022 Dec; 12(6):937. PubMed ID: 36573113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective Longitudinal Serosurvey of Healthcare Workers in the First Wave of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic in a Quaternary Care Hospital in Munich, Germany.
    Weinberger T; Steffen J; Osterman A; Mueller TT; Muenchhoff M; Wratil PR; Graf A; Krebs S; Quartucci C; Spaeth PM; Grabein B; Adorjan K; Blum H; Keppler OT; Klein M
    Clin Infect Dis; 2021 Nov; 73(9):e3055-e3065. PubMed ID: 33388756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of monoclonal antibody therapy for nosocomial SARS-CoV-2 infection in patients at high risk for severe COVID-19: experience from a tertiary-care hospital in Germany.
    Koehler J; Ritzer B; Weidlich S; Gebhardt F; Kirchhoff C; Gempt J; Querbach C; Hoffmann D; Haller B; Schmid RM; Schneider J; Spinner CD; Iakoubov R
    Infection; 2021 Dec; 49(6):1313-1318. PubMed ID: 34244967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outbreak of SARS-CoV-2 B.1.1.7 Lineage after Vaccination in Long-Term Care Facility, Germany, February-March 2021.
    Tober-Lau P; Schwarz T; Hillus D; Spieckermann J; Helbig ET; Lippert LJ; Thibeault C; Koch W; Bergfeld L; Niemeyer D; Mühlemann B; Conrad C; Kasper S; Münn F; Kunitz F; Jones TC; Suttorp N; Drosten C; Sander LE; Kurth F; Corman VM
    Emerg Infect Dis; 2021 Aug; 27(8):2169-2173. PubMed ID: 34102098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erratum: Evaluation of prevalence and risk factors for bloodstream infection in severe coronavirus disease 2019 (COVID-19) patients - CORRIGENDUM.
    Erbay K; Ozger HS; Guzel Tunccan O; Gaygısız Ü; Buyukkoruk M; Sultanova F; Yıldız M; Boyacı Dündar N; Aydoğdu M; Bozdayi G; Dizbay M
    Antimicrob Steward Healthc Epidemiol; 2022; 2(1):e117. PubMed ID: 36483344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to Commentary on "The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients".
    Li YC; Bai WZ; Hashikawa T
    J Med Virol; 2020 Jul; 92(7):707-709. PubMed ID: 32246783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 Co-infection with Legionella pneumophila in 2 Tertiary-Care Hospitals, Germany.
    Verhasselt HL; Buer J; Dedy J; Ziegler R; Steinmann J; Herbstreit F; Brenner T; Rath PM
    Emerg Infect Dis; 2021 May; 27(5):1535-1537. PubMed ID: 33900187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postvaccination infections among staff of a tertiary care hospital after vaccination with severe acute respiratory syndrome coronavirus 2 vector and mRNA-based vaccines.
    Brunner-Ziegler S; Spath T; Kornek G; König F; Parschalk B; Schnetzinger M; Straßl RP; Savic R; Foit A; Resch H; Thalhammer F
    Clin Microbiol Infect; 2022 Apr; 28(4):596-601. PubMed ID: 34915073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe Acute Respiratory Syndrome Coronavirus 2 Outbreak Related to a Nightclub, Germany, 2020.
    Muller N; Kunze M; Steitz F; Saad NJ; Mühlemann B; Beheim-Schwarzbach JI; Schneider J; Drosten C; Murajda L; Kochs S; Ruscher C; Walter J; Zeitlmann N; Corman VM
    Emerg Infect Dis; 2020 Feb; 27(2):645-648. PubMed ID: 33263514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological autoimmune diseases following vaccinations against SARS-CoV-2: a case series.
    Kaulen LD; Doubrovinskaia S; Mooshage C; Jordan B; Purrucker J; Haubner C; Seliger C; Lorenz HM; Nagel S; Wildemann B; Bendszus M; Wick W; Schönenberger S
    Eur J Neurol; 2022 Feb; 29(2):555-563. PubMed ID: 34668274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged SARS-CoV-2 RNA Shedding from Therapy Cat after Cluster Outbreak in Retirement Home.
    Schulz C; Wylezich C; Wernike K; Gründl M; Dangel A; Baechlein C; Hoffmann D; Röhrs S; Hepner S; Ackermann N; Sing A; Pink I; Länger B; Volk HA; Becher P; Sutter G; Neubauer-Juric A; von Köckritz-Blickwede M; Beer M; Volz A
    Emerg Infect Dis; 2021 Jul; 27(7):1974-1976. PubMed ID: 34152973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to a cluster of Severe Acute Respiratory Syndrome Coronavirus 2 cases at a diagnostic laboratory.
    Opperman CJ; Marais GJK; Naidoo M; Hsiao M; Samodien N
    Afr J Lab Med; 2020; 9(1):1307. PubMed ID: 32934912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Universal testing for severe acute respiratory syndrome coronavirus 2 in 2 Philadelphia hospitals: carrier prevalence and symptom development over 2 weeks.
    Bender WR; Hirshberg A; Coutifaris P; Acker AL; Srinivas SK
    Am J Obstet Gynecol MFM; 2020 Nov; 2(4):100226. PubMed ID: 32954248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.